Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cancer in Ecuadorian subjects with Laron syndrome (ELS)89
Radioiodine: 80 years and counting; the past, present, and future65
Association of DNA methylation with steroidogenic enzymes in Cushing’s adenoma53
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing49
Targeting growth hormone in cancer: future perspectives43
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma42
Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer42
Management of early-stage metastatic prostate cancer: appraisal of locoregional treatments and radiation therapy, with or without immunomodulation39
TLR4 inhibition suppresses growth in oestrogen-induced prolactinoma models36
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients35
Congenital hypothyroidism and thyroid cancer35
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy34
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas30
Acknowledgement to reviewers30
Celebrating the 80th anniversary of hormone ablation for prostate cancer29
One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones27
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications27
Advancements and challenges in pheochromocytoma and paraganglioma research: a collection of insights26
A pilot study of the immune microenvironment of GI neuroendocrine carcinoma26
Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review26
Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer25
Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma25
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management24
Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis24
0.042485952377319